Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
The Journal of Infectious Diseases
|
February 1, 1997
Development of a more thermostable poliovirus vaccine
J B Milstien, S M Lemon, P F Wright
American Journal of Hospital Pharmacy
|
November 1, 1986
Food and Drug Administration monitoring of adverse drug reactions
J M Sills, L A Tanner, J B Milstien
Journal of Virology
|
September 1, 1977
Correlation of virus polypeptide structure with attenuation of poliovirus type 1
J B Milstien, J R Walker, L J Eron
Pediatrics
|
August 1, 1987
Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: an analysis after 1 year of marketing
J B Milstien, T P Gross, J N Kuritsky
Science (New York, N.Y.)
|
July 29, 1977
Bacteriophages in live virus vaccines: lack of evidence for effects on the genome of rhesus monkeys
J B Milstien, J R Walker, J C Petricciani
Intervirology
|
January 1, 1983
Identification and characterization of measles virus 50S RNA
R C Dunlap, J B Milstien, M L Lundquist
Biologicals : Journal of the International Association of Biological Standardization
|
February 1, 2000
Re: Laboratory tests for live attenuated poliovirus vaccine. Subhash C. Arya; Biologicals, Volume 26, pp. 245-246, 1998
J B Milstien, M Zaffran, D J Wood, et al.
Bulletin of the World Health Organization
|
April 1, 2000
Developing a national system for dealing with adverse events following immunization
U Mehta, J B Milstien, P Duclos, et al.
Journal of Virology
|
November 1, 1979
Cell-free synthesis of measles virus proteins
J Sprague, L J Eron, A S Seifried, et al.
Annals of Internal Medicine
|
August 1, 1985
Streptokinase and the Guillain-Barré syndrome
J B Arrowsmith, J B Milstien, J N Kuritsky, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
The Journal of Infectious Diseases
|
February 1, 1997
Development of a more thermostable poliovirus vaccine
J B Milstien, S M Lemon, P F Wright
American Journal of Hospital Pharmacy
|
November 1, 1986
Food and Drug Administration monitoring of adverse drug reactions
J M Sills, L A Tanner, J B Milstien
Journal of Virology
|
September 1, 1977
Correlation of virus polypeptide structure with attenuation of poliovirus type 1
J B Milstien, J R Walker, L J Eron
Pediatrics
|
August 1, 1987
Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: an analysis after 1 year of marketing
J B Milstien, T P Gross, J N Kuritsky
Science (New York, N.Y.)
|
July 29, 1977
Bacteriophages in live virus vaccines: lack of evidence for effects on the genome of rhesus monkeys
J B Milstien, J R Walker, J C Petricciani
Intervirology
|
January 1, 1983
Identification and characterization of measles virus 50S RNA
R C Dunlap, J B Milstien, M L Lundquist
Biologicals : Journal of the International Association of Biological Standardization
|
February 1, 2000
Re: Laboratory tests for live attenuated poliovirus vaccine. Subhash C. Arya; Biologicals, Volume 26, pp. 245-246, 1998
J B Milstien, M Zaffran, D J Wood, et al.
Bulletin of the World Health Organization
|
April 1, 2000
Developing a national system for dealing with adverse events following immunization
U Mehta, J B Milstien, P Duclos, et al.
Journal of Virology
|
November 1, 1979
Cell-free synthesis of measles virus proteins
J Sprague, L J Eron, A S Seifried, et al.
Annals of Internal Medicine
|
August 1, 1985
Streptokinase and the Guillain-Barré syndrome
J B Arrowsmith, J B Milstien, J N Kuritsky, et al.
Page
of 5